Page last updated: 2024-10-24

substantia propria of cornea development

Definition

Target type: biologicalprocess

The process whose specific outcome is the progression of a substantia propria of cornea over time, from its formation to the mature structure. [GO_REF:0000094, GOC:TermGenie, PMID:12556382]

The substantia propria of the cornea, the middle layer of the cornea, undergoes a complex developmental process that involves the coordinated interaction of multiple cell types and signaling pathways. This process begins during embryonic development and continues into adulthood.

**1. Mesenchymal Cell Differentiation:**
- During early development, the corneal stroma is initially populated by mesenchymal cells derived from the neural crest.
- These mesenchymal cells undergo a series of differentiation steps, becoming specialized fibroblasts called keratocytes.
- These keratocytes are responsible for synthesizing and depositing the extracellular matrix (ECM) components of the substantia propria.

**2. Extracellular Matrix Deposition:**
- Keratocytes produce and secrete various ECM components, including collagen, proteoglycans, and glycoproteins.
- The major collagen type found in the substantia propria is type I collagen, which forms a dense, organized network of fibrils.
- Other collagen types, such as type V and type VI, are also present and contribute to the structural integrity of the stroma.
- Proteoglycans, such as keratan sulfate and chondroitin sulfate, bind water, helping to maintain the hydration and transparency of the cornea.

**3. Collagen Fibril Organization:**
- Collagen fibrils are assembled into lamellae, thin sheets of parallel fibers that are stacked on top of each other.
- The lamellae are oriented in a regular, alternating pattern, creating a highly organized structure that contributes to the cornea's strength and transparency.
- The arrangement of collagen fibrils is precisely controlled by a variety of molecular signals and cellular interactions.

**4. Vascularization and Innervation:**
- During embryonic development, the substantia propria is transiently vascularized.
- However, these blood vessels regress as the cornea matures, leaving the substantia propria avascular.
- The cornea is also innervated by sensory nerves that provide pain and touch sensation.

**5. Ongoing Remodeling and Repair:**
- Even after the cornea has matured, the substantia propria undergoes continuous remodeling and repair.
- Keratocytes have the ability to proliferate and secrete new ECM components, allowing the cornea to adapt to changes in its environment.
- In response to injury, keratocytes can also activate wound-healing processes, leading to scar formation.

**6. Factors Influencing Development:**
- The development of the substantia propria is influenced by a variety of factors, including genetic predisposition, environmental factors, and systemic diseases.
- Mutations in genes involved in ECM synthesis or collagen fibril organization can lead to corneal disorders.
- Exposure to environmental toxins or trauma can also damage the substantia propria, impairing its function.

The development of the substantia propria is a complex and dynamic process that is essential for maintaining the structural integrity and transparency of the cornea. Understanding the underlying mechanisms of this process is crucial for developing treatments for corneal diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Potassium voltage-gated channel subfamily KQT member 3A voltage-gated potassium channel subunit KCNQ3 that is encoded in the genome of human. []Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
N-(2-aminoethyl)-5-chloro-1-naphthalenesulfonamidenaphthalenes;
sulfonic acid derivative
flupirtineflupirtine: RN given refers to parent cpd without isomeric designationaminopyridine
ezogabineezogabine : A substituted aniline that is benzene-1,2,4-triamine bearing ethoxycarbonyl and 4-fluorobenzyl substituents at positions N-1 and N-4 respectively. An anticonvulsant used to treat seizures associated with epilepsy in adults.

ezogabine: structure in first source
carbamate ester;
organofluorine compound;
secondary amino compound;
substituted aniline
anticonvulsant;
potassium channel modulator
bms204352BMS204352: a calcium-sensitive opener of maxi-K potassium channels; structure in first source
N-(2,4,6-trimethylphenyl)-3-bicyclo[2.2.1]heptanecarboxamidemonoterpenoid
n-(6-chloropyridin-3-yl)-4-fluorobenzamideN-(6-chloropyridin-3-yl)-4-fluorobenzamide: structure in first source
ica 27243N-(6-Chloropyridin-3-yl)-3,4-difluorobenzamide: a KCNQ2/3 channel activator; structure in first source
a 803467A 803467: an Nav1.8 sodium channel blocker; structure in first source